Oleamide

This note is educational and is not personal medical advice. Effects vary by baseline status, dose, product quality, medications, sleep debt, diet, and health conditions.

Summary / What it does

Oleamide is an endogenous fatty acid amide that accumulates in cerebrospinal fluid during sleep deprivation and appears to be a physiological sleep-inducing signal. It works through CB1 receptors, GABAergic potentiation, and serotonin modulation to produce sedation and improve sleep quality.

Useful cross-links: Sleep Support, Neurotransmitter Balance. Its effects are best evaluated through the Acute & Instant Effects pattern rather than as a single isolated effect.

How it works in the brain (detailed scientific mechanisms)

Oleamide is synthesized in neurons and released into the CNS where it accumulates during sleep deprivation, suggesting it is part of the homeostatic sleep-pressure signaling system. Oleamide activates CB1 cannabinoid receptors with moderate affinity — lower than anandamide but sufficient to produce hypnotic effects. Its endocannabinoid-like activity reduces neuronal excitability, promotes GABAergic tone, and may interact with serotonin (5-HT2A and 5-HT7) receptors to further dampen arousal circuits.

Oleamide is degraded by FAAH (fatty acid amide hydrolase), the same enzyme that breaks down anandamide. FAAH inhibition (by CBD or other compounds) raises both anandamide and oleamide levels simultaneously, which may partially explain why CBD improves sleep. Unlike direct GABA agonists or benzodiazepines, oleamide’s sedative mechanism is more modulatory — it amplifies existing GABAergic and endocannabinoid sleep tone rather than forcing the system into sedation, which may preserve sleep architecture better than hard sedatives.

Related mechanism notes: Sleep Support, Neurotransmitter Balance.

Different variations/forms

Capsules or powder are available from research suppliers. Not a mainstream supplement — quality control and vendor reliability require verification.

Time to action / onset

30-90 minutes orally. Sedation is typically the first noticeable effect.

Half-life

Approximately 2-4 hours, limited by FAAH-mediated degradation. Effects are generally not present by morning at typical doses.

Dosage

Studied range is 100-600 mg taken 30-60 minutes before sleep. Start at 100-200 mg to assess sedation response before increasing.

Positive effects

Positive effects may include faster sleep onset, improved sleep quality and depth, reduced nighttime waking, and a calm pre-sleep state.

Reported Effects

Users describe oleamide as producing a genuine sleepiness rather than forced sedation — a natural drift toward sleep that feels similar to the body’s own sleep signals. Some describe a pleasant pre-sleep calm and vivid dreams at higher doses. Negative reports include feeling groggy the next morning (dose-dependent), the need to be in bed promptly after taking it, and inconsistent sourcing quality affecting potency.

Side effects / contraindications

Side effects include next-morning grogginess at higher doses, additive CNS depression with other sedatives, alcohol, or benzodiazepines. Limited long-term human safety data — not for routine daily use without medical oversight.

Where it is found in food or nature (natural sources)

Oleamide is an endogenous brain lipid. Dietary oleic acid (from olive oil, avocado, nuts) is the structural precursor, though dietary intake does not meaningfully raise brain oleamide. Coffee has been identified as a source of oleamide, which may contribute to the post-coffee relaxation some describe.

Protocol

Take 100–400 mg 30–60 minutes before bed. Start at the lower end. Do not combine with alcohol, benzodiazepines, or other sedatives without medical guidance. Be in or near bed when the sedative effect begins. Morning grogginess signals the dose is too high — reduce by 100 mg increments. Can be paired with Melatonin (0.3–1 mg) for circadian timing + sleep quality support.

Key Research

• Cravatt et al. (1995): Original oleamide discovery paper demonstrated sleep-inducing effects in cats and rats, establishing its role as a physiological sleep factor.
• Lerner et al. (1994): Isolated oleamide from sleep-deprived cat CSF and characterized its structure and endogenous sleep-promoting properties.
• Huidobro-Toro & Alger (1997): Demonstrated GABAergic potentiation mechanism of oleamide in rat hippocampal slice preparations.

Forms & Sourcing

Available from a small number of supplement vendors (Pure Rawz, Ceretropic) and research chemical suppliers. Verify COA — the market is small and quality control varies. Not widely stocked in mainstream supplement stores.

Other notes

Oleamide sits near Melatonin, Glycine, and CBD in the sleep support cluster of the wiki. Its endocannabinoid-related mechanism makes it distinct from GABAergic sedatives and potentially more sleep-architecture preserving.

Related notes: Melatonin, Glycine, CBD, Magnesium, L-Theanine, Sleep Support